Literature DB >> 19399378

[Cutaneous marginal zone lymphoma (SALT) and infection with Borrelia burgdorferi].

M Fühler1, K W Ottmann, M Tronnier.   

Abstract

A relationship between Borrelia burgdorferi and the development of cutaneous B-cell lymphoma (CBCL) has been long discussed. B. burgdorferi DNA has been detected in patients with CBCL and a response of CBCL to antibiotics has been observed. In our patient with a Borrelia infection, a marginal zone lymphoma (SALT) regressed after ceftriaxone therapy. This further case of a combined appearance of CBCL and B. burgdorferi underlines a possible relationship as an example of an infectious trigger in tumorigenesis.

Entities:  

Mesh：

Year:  2010        PMID： 19399378     DOI： 10.1007/s00105-009-1766-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  7 in total

1.  Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases.

Authors:  C Garbe; H Stein; D Dienemann; C E Orfanos
Journal:  J Am Acad Dermatol       Date:  1991-04       Impact factor: 11.527

2.  Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a.

Authors:  B Kütting; G Bonsmann; D Metze; T A Luger; L Cerroni
Journal:  J Am Acad Dermatol       Date:  1997-02       Impact factor: 11.527

3.  Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma.

Authors:  L Cerroni; N Zöchling; B Pütz; H Kerl
Journal:  J Cutan Pathol       Date:  1997-09       Impact factor: 1.587

Review 4.  [Cutaneous B cell lymphoma in chronic Borrelia burgdorferi infection. Report of 2 cases and a review of the literature].

Authors:  C Garbe; H Stein; H Gollnick; W Taud; C E Orfanos
Journal:  Hautarzt       Date:  1988-11       Impact factor: 0.751

5.  Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States.

Authors:  G S Wood; N V Kamath; J Guitart; P Heald; S Kohler; B R Smoller; L Cerroni
Journal:  J Cutan Pathol       Date:  2001-11       Impact factor: 1.587

6.  Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland.

Authors:  J R Goodlad; M M Davidson; K Hollowood; C Ling; C MacKenzie; I Christie; P J Batstone; D O Ho-Yen
Journal:  Am J Surg Pathol       Date:  2000-09       Impact factor: 6.394

7.  Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma.

Authors:  L Heinzerling; R Dummer; W Kempf; M H Schmid; G Burg
Journal:  Arch Dermatol       Date:  2000-03
  7 in total
  1 in total

Review 1.  The role of infectious agents, antibiotics, and antiviral therapy in the treatment of extranodal marginal zone lymphoma and other low-grade lymphomas.

Authors:  Laahn H Foster; Craig A Portell
Journal:  Curr Treat Options Oncol       Date:  2015-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.